Medicare bill aims to block drugmakers from misclassifying drugs
A bipartisan bill introduced Tuesday by members of the Senate Finance Committee would prevent drugmakers from profiting by misclassifying drugs to Medicare as generics.
The bill is in response to a lawsuit against Mylan N.V. (NASDAQ:MYL) for misclassifying its...